当前位置:首页 > 报告详情

MRC资助者访谈.pdf

上传人: 芦苇 编号:1146371 2026-02-14 6页 752.12KB

1、Medical Research Council and support of industry collaborationsDr Emma MitchellMRC Programme ManagerMRC visionMRC funds world-leading discovery and translational research to accelerate diagnosis,advance treatment and prevent human illness.Integrated understanding of diseaseExploring mechanisms acros

2、s scales,from molecules to populationsPrecision Prevention Understanding illness to protect and promote healthEarly Diagnosis Enabling intervention at the earliest opportunityAdvanced treatments Treating patients safely with precisionUnderpinning capability&infrastructure People and systems deliveri

3、ng research to improve healthInnovative companies that scale and grow across the UKImproving public services and delivering better outcomes for citizensNew discoveries from excellent curiosity-led researchMRC prioritiesInfections and Immunity BoardPopulation and Systems Medicine BoardMolecular and C

4、ellular Medicine BoardNeurosciences and Mental Health BoardBoardsPanelsTraining and CareersTranslationMajor InvestmentsCross-cutting areasInternationalPopulation HealthData SciencePolicy,Ethics and GovernancePublic PartnershipsInc.Research Grants,Programme Grants,NIRGs and Partnership GrantsClinical

5、 and non-clinicalDPFS,Gap Fund,EMECoREStrategyMedical Research Council how we fundMRC Translational ResearchGap FundClinical and Translational MedicinePreclinical Clinical DPFSFellowships(Clinical,Non-Clinical)4 Research Boards(MCMB,NMHB,PSMB,IIB)MRC/NIHREME Experimental Medicine PanelMRC Impact Acc

6、eleration Account11m pa*39m pa15m paOther research councils(BBSRC/EPSRC)Industry Collaborations Supporting industry partnerships through the Industry Collaboration Framework in our grant funding opportunities.Supports involvement of industr

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
1. **MRC愿景与优先领域**:资助世界领先的发现与转化研究,加速诊断、推进治疗、预防疾病,重点关注感染与免疫、分子与细胞医学等4个研究委员会,以及数据科学、伦理治理等跨领域方向。 2. **核心资助数据**:年度资助包括转化研究(约£1100万)、临床与转化医学(约£3900万)、DPFS与Gap基金(约£1500万),另有行业合作框架支持伙伴关系。 3. **资助策略**:通过研究计划、合作基金等支持从分子到人群的疾病机制研究,推动精准预防、早期诊断及先进治疗,同时强化基础设施与人才培养。 4. **行业合作**:通过行业合作框架整合企业资源,管理知识产权共享,确保合规,并战略性地联合资助学术研究。
**MRC愿景?** - MRC的核心目标是什么?如何通过研究加速诊断、治疗和预防疾病? **行业合作?** - MRC如何支持与企业的合作?有哪些具体的合作框架和IP管理机制? **资金分配?** - MRC的 translational research 资金流向哪些领域?如何平衡基础研究与临床应用?
客服
商务合作
小程序
服务号
折叠